SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-24-138250
Filing Date
2024-12-19
Accepted
2024-12-19 08:30:08
Documents
11
Period of Report
2024-12-19
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K rare-20241219.htm   iXBRL 8-K 45539
  Complete submission text file 0000950170-24-138250.txt   156872

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT rare-20241219.xsd EX-101.SCH 23898
13 EXTRACTED XBRL INSTANCE DOCUMENT rare-20241219_htm.xml XML 4516
Mailing Address 60 LEVERONI COURT NOVATO CA 94949
Business Address 60 LEVERONI COURT NOVATO CA 94949 415-483-8800
Ultragenyx Pharmaceutical Inc. (Filer) CIK: 0001515673 (see all company filings)

IRS No.: 272546083 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36276 | Film No.: 241561054
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)